Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 3113 of 3330
Next
>>
>
77801 to 77825 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.0533	uM	5898.074	0.9240	0.7903	0.7134
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.267	uM	5898.074	0.8375	0.5597	0.7134
600MPE	HR+	Luminal	Triciribine	AKT	AKT	1.33	uM	5898.074	0.7778	0.4062	0.7134
600MPE	HR+	Luminal	Triciribine	AKT	AKT	6.67	uM	5898.074	0.6618	0.1212	0.7134
600MPE	HR+	Luminal	Triciribine	AKT	AKT	33.3	uM	5898.074	0.5914	-0.0423	0.7134
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.0000853	uM	5899.074	0.9447	0.8756	0.8860
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.000427	uM	5899.074	0.9642	0.9195	0.8860
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.00213	uM	5899.074	0.9582	0.9060	0.8860
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.0107	uM	5899.074	0.8981	0.7715	0.8860
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.0533	uM	5899.074	0.8180	0.5943	0.8860
600MPE	HR+	Luminal	Triciribine	AKT	AKT	0.267	uM	5899.074	0.7813	0.5138	0.8860
600MPE	HR+	Luminal	Triciribine	AKT	AKT	1.33	uM	5899.074	0.7920	0.5371	0.8860
600MPE	HR+	Luminal	Triciribine	AKT	AKT	6.67	uM	5899.074	0.6846	0.3041	0.8860
600MPE	HR+	Luminal	Triciribine	AKT	AKT	33.3	uM	5899.074	0.5575	0.0341	0.8860
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	0.0000853	uM	5900.074	0.9891	0.9910	2.4189
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	0.000427	uM	5900.074	1.0166	1.0137	2.4189
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	0.00213	uM	5900.074	0.9435	0.9525	2.4189
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	0.0107	uM	5900.074	0.8128	0.8358	2.4189
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	0.0533	uM	5900.074	0.5076	0.5110	2.4189
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	0.267	uM	5900.074	0.3508	0.2970	2.4189
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	1.33	uM	5900.074	0.0059	-0.7612	2.4189
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	6.67	uM	5900.074	0.0930	-0.2510	2.4189
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	33.3	uM	5900.074	0.0341	-0.5051	2.4189
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	0.0000853	uM	5901.074	0.9459	0.9414	1.8718
AU565	HER2amp	Luminal	Triciribine	AKT	AKT	0.000427	uM	5901.074	0.9862	0.9852	1.8718

|<
<<
Previous
Page 3113 of 3330
Next
>>
>
77801 to 77825 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)